Approval · Notice of Compliance 10186 · 2009
BANAMINE: Notice of Compliance 10186
Issued May 1, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10186
- Date
- May 1, 2009
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in ownership
- Therapeutic class
- Anti-inflammatory / analgesic / antipyretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BANAMINE | 00465305 | Marketed |
Medicinal ingredients
- FLUNIXIN MEGLUMINE 50 MG per ML